Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

Alzheimer’s disease has rightly been characterised as a ‘silent pandemic’, with the number of Americans over 65 who are ...

Bertolini has been with The Considered since its beginnings in 2021, first as senior operations manager, then vice president ...

The UK government has published its 10 Year Health Plan for England, which will see millions of patients be treated and cared ...

As co-heads of the Communiqué Awards judging panel for the Action on Workplace DEI category, I spoke to Avril Lee, Chair of ...

AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...

The Communiqué Awards returned for its 27th year on 3 July to celebrate excellence in healthcare communications and showcase ...

With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience ...

All attendees shared a vested interest in the rapidly evolving cancer treatment landscape. Nowhere was the vastness of that ...

The company formerly known as BeiGene announced that the Committee for Medicinal Products for Human Use (CHMP) has ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

In Measure for Measure, Lucio points out the damage that doubts can do: ‘Our doubts are traitors, and make us lose the good ...